Form D · Biotechnology
SANUWAVE Health, Inc.
Eden Prairie, MN · CIK 0001417663
Offering snapshot reported Jul 2, 2024 · SEC filing
- Reported sold
- $1.8M Offering amount: $1.8M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2024 | Initial | $1,800,000 | No comparison | 9 | SEC filing |
| Feb 5, 2024 | Initial | $4,557,650 | No comparison | 19 | SEC filing |
| Jan 5, 2024 | Initial | $1,861,250 | No comparison | 15 | SEC filing |
| Aug 7, 2023 | Initial | $3,038,585 | No comparison | 17 | SEC filing |
| May 16, 2023 | Initial | $1,227,778 | No comparison | 11 | SEC filing |
| Dec 27, 2022 | Initial | $3,981,950 | No comparison | 32 | SEC filing |
| Aug 19, 2022 | Initial | $16,153,594 | No comparison | 46 | SEC filing |
| Aug 21, 2020 | Initial | $24,710,000 | No comparison | 46 | SEC filing |
| Jan 25, 2018 | Initial | $3,029,750 | No comparison | 42 | SEC filing |
| Mar 19, 2014 | Initial | $9,280,000 | No comparison | 10 | SEC filing |
| Feb 25, 2014 | Initial | $278,500 | No comparison | 1 | SEC filing |
| Feb 7, 2014 | Initial | $170,000 | No comparison | 3 | SEC filing |
| Jan 10, 2014 | Initial | $128,500 | No comparison | 1 | SEC filing |
| Aug 29, 2013 | Initial | $360,000 | No comparison | 6 | SEC filing |
| Feb 27, 2013 | Amendment | $2,000,000 | $1,620,000vs Nov 28, 2012 | 17 | SEC filing |
| Nov 28, 2012 | Initial | $380,000 | No comparison | 5 | SEC filing |
| Apr 19, 2011 | Initial | $9,114,929 | No comparison | 28 | SEC filing |
| Oct 8, 2010 | Initial | $800,000 | No comparison | 4 | SEC filing |
| Mar 12, 2010 | Initial | $400,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-517672
Source: Form D, filed Jul 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Blizard | Director |
| Christopher M. Cashman | Director, Executive |
| Joseph Chiarelli | Director, Executive |
| Iulian Cioanta | Executive |
| Morgan C. Frank | Director, Executive |
| Barry J. Jenkins | Executive |
| Maj Britt Kaltoft | Director |
| Ian Miller | Director |
| John F Nemelka | Director |
| Thomas Price | Director |
| Kevin Richardson | Executive |
| Kevin A. Richardson Ii | Director |
| Kevin A. Richardson, Ii | Executive |
| Toni Rinow | Executive |
| Thomas H. Robinson | Director |
| Alan L Rubino | Director |
| John Schlechtweg | Executive |
| Peter Sorensen | Executive |
| Peter Stegagno | Executive |
| Peter Stegano | Executive |
| A. Michael Stolarski | Director |
| Michael A Stolarski | Director |
| Anthony Michael Stolarski | Director |
| A. Michael Stolarski | Director |
| Lisa Sundstrom | Executive |
| Lisa A Sundstrum | Executive |
| James Tyler | Director |
| Jim Tyler | Director |
| Andrew Walko | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11495 Valley View Road
Eden Prairie, MN, 55344
Eden Prairie, MN, 55344